Category: Drug Testing News

on

New FRA Rules Expand Drug and Alcohol Testing

Dec 1 2016

New FRA Rules Expand Drug and Alcohol Testing

Separate rules increase protections, add Maintenance of Way workers to drug and alcohol testing policy

The U.S. Department of Transportation’s (DOT) Federal Railroad Administration (FRA) announced it has issued two final rules to better protect railroad employees working on or near railroad tracks.

One rule amends the existing Roadway Worker Protection Regulation, while the second rule, Control of Alcohol and Drug Use, amends the FRA’s current drug and  alcohol testing regulations expands the requirements to now cover maintenance of way (MOW) employees.

The second rule fulfills a requirement of the Rail Safety Improvement Act of 2008.

The Roadway Worker Protection final rule amendments will:

  • Resolve various interpretations that have developed since the rule went into effect almost 20 years ago;
  • Implement FRA’s Railroad Safety Advisory Committee’s (RSAC) consensus recommendations;
  • Organize certain FRA Technical Bulletins;
  • Codify a FAST Act mandate by adopting new requirements governing redundant signal protections;
  • Address the safe movement of roadway maintenance machinery over signalized non-controlled track (not under a dispatcher’s control); and
  • Amend certain qualification requirements for roadway workers.

The most recent amendments require that job briefings include information for roadway worker groups on the following:

  • Accessibility of the roadway worker in charge
  • Standards for how “occupancy behind” train authorities (when the authority for a work crew does not begin until the train has passed the area) can be used; and
  • Require annual training for any individual serving as a roadway worker in charge.

“These new rules add another layer of protection for workers who work along and near railroad tracks and will help us reduce preventable worker injuries and fatalities,” said FRA Administrator Sarah E. Feinberg.

These updated changes came in response to a congressional mandate and recommendations by the National Transportation Safety Board (NTSB).  These changes allow the FRA to broaden the scope of its existing drug and alcohol testing regulation to include Maintenance of Way (MOW) employees.

Currently, a MOW employee is only drug and alcohol tested when he or she has died as a result of an accident or incident. MOW employees will now be fully subject to FRA’s drug and alcohol testing that includes random testing, post-accident testing, reasonable suspicion testing, reasonable cause testing, pre-employment testing, return-to-duty testing and follow-up testing.

“Whether you are an engineer, conductor or someone working alongside the tracks, safety requires alertness. Any reduction in awareness caused by drugs or alcohol use can often be the difference between life and death,” Feinberg added.

The final Roadway Worker Protection rule is effective April 1, 2017. The Control of Alcohol and Drug Use goes into effect one year after publication.

http://www.fra.dot.gov/eLib/details/L17465

http://www.fra.dot.gov/eLib/Details/L17467

For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

Methamphetamine Drug Use On The Rise

Nov 8 2016

Methamphetamine Drug Use On The Rise

Billings Montana – Methamphetamines (Meth) has overtaken marijuana as the most common drug found in addition to alcohol in DUI samples sent to the state crime lab this past year.

Meth has also been detected more frequently in other types cases handled by Crime lab’s toxicology division, per a summary report from the Montana Department of Justice’s Forensic Science Division.

“I think that’s the real take-home of this summary, is the massive increase in methamphetamine,” said Scott Larson, toxicology supervisor at the crime lab.

Even after the spike in Methamphetamine positive results, alcohol remains the most frequent substance found in DUI toxicology cases.

For example, in 2015, alcohol was the only substance detected in 2,277 out of 3,380 total DUI cases tested calendar year.

The lab had 294 DUI cases involving meth, and the drug concentration of the samples screened increased 123 percent. These numbers are up from 2011, when state toxicologists administered 73 DUI samples that tested positive for meth.

These results illustrate that Marijuana used to be the most common substance after alcohol discovered in DUI blood tests. However, in 2015, meth became more prevalent in DUI blood tests, as per the lab.

The toxicology division of the state crime lab in Missoula also performs postmortem drug screens for medical examiners and examines drug and alcohol test results for cases that involve drug-endangered children. The lab also examines urine tests for the Department of Corrections on inmates and individuals on probation.

The lab analyses specimens for a variety of different drugs — such as marijuana, prescription narcotics, hallucinogens and inhalants. Over the years the overall number of positive drug findings has decreased.

DUIs continue to make up the largest caseload which account for more over half of the 6,139 cases handled in 2015. In most DUI test results, alcohol is the only substance present in the blood sample.

However, meth has increased in other test areas. One area includes postmortem drug screens, in 2011 the lab had 20 confirmed positive cases for meth but the rate has increased to 73 positive cases out of a total 801 cases in 2015.

The study also showed that Urine tests conducted on probationers and parolees have seen a dramatic spike in positive results in regards to meth.

For example, there were 1,192 urinalysis cases handled by the lab in 2015 and more than 550 turned up positive for meth. In 2011 there were fewer than 200 confirmed cases and no other drug has spiked so rapidly.

Amphetamines are classified as a stimulant and an appetite suppressant that targets the central nervous system by increasing the release of certain chemicals (“neurotransmitters”) in the brain.

Amphetamines are a Schedule II drug that can be prescribed for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD). Physical symptoms may include restlessness, tremors, rapid breathing, confusion, panic and seizures. Due to its high risk for potential for abuse and addiction, physicians prefer using other treatment methods. Common trade names of amphetamine-containing drugs are Adderall®, Dexedrine® and Vyvanse®.
Methamphetamine, often referred to as meth, crystal, crank and ice, is an extremely addictive stimulant drug. Meth can be taken orally, smoked, snorted, or dissolved in water or alcohol and injected.

According to the National Institute on Drug Abuse, even small amounts of methamphetamine can cause increased physical activity, decreased appetite, increased respiration, rapid heart rate, irregular heartbeat and increased blood pressure.

Methamphetamine is also available by prescription for limited medical uses (treatment of obesity and attention deficit hyperactivity disorder) under the trade name of Desoyxn®.

See Article


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here
 

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

DEA and Partners Hold Prescription Drug Take Back Day Saturday

Oct. 20 2016

DEA and Partners Hold Prescription Drug Take Back Day Saturday

Thousands of communities participate in this weekend’s event

OCT 17 – (Washington, DC) – DEA set to repeat on of its most popular community programs this weekend, National Prescription Drug Take Back Day.  On Saturday October 22 between 10 a.m. and 2 p.m. the public can dispose of their unused, unwanted prescription medications at one of 4,700 collection sites nationwide, operated by 3,800 local law enforcement agencies and other community partners.  The service is free of charge, no questions asked.

 

As referenced in previous articles, America is currently experiencing an epidemic of addiction, overdose and death attributed to the abuse of prescription drugs and particularly opioid painkillers.

Approximately 6.4 million Americans ranging from age 12 and over (representing 2.4 percent of the population) abuse prescription drugs.  The 2015 National Survey on Drug Use and Health released last month that their research reveals that more individuals abuse cocaine, heroin, hallucinogens, and methamphetamine combined.  Drug overdoses are now the leading cause of injury-related death in the United States, surpassing deaths from motor vehicle crashes or firearms.  The majority of prescription drug abusers report that they obtain their drugs from friends and family, including from the home medicine cabinet.

 

Last April, during its 11th Take Back Day even, the DEA and over 4,200 of its national, tribal, and community law enforcement partners collected 893,498 pounds (about 447 tons) of unwanted prescription drugs at almost 5,400 collection sites.  Since the program’s inception, six years ago, about 6.4 million pounds (about 3,200 tons) of drugs have been collected. That translates to more than a quarter pound of pills for each of the 25 million children age 12 to 17 in America.

 

Individuals can  now find a nearby collection site by visiting www.dea.gov, clicking on the “Got Drugs?” icon, and following the links to a database where they enter their zip code.  Or they can call 800-882-9529.  Only pills and other solids, like patches, can be brought to the collection sites—liquids and needles or other sharps will not be accepted.

on

Random Drug Testing Program in Missouri Schools

Oct. 3 2016

Random Drug Testing Program in Missouri Schools

Belton School District is the latest district in Missouri to start randomly testing its students for drugs.  This policy was created by the district’s students who came up with the idea.

Under this policy, students with a permit to drive to school are now considered fair game to be randomly tested. Furthermore, any student in Grades 7-12 who is involved with an extracurricular activity would be required under this policy as well.

The school district provided the parents with letters discussing the policy during open enrollment.

Some parents were strongly on board with the decision, while others challenged the policy.

Many parents, interviewed were surprised that it was the district’s students that created and developed the idea.

Belton School District Superintendent Andy Underwood. Stated that “There was concern from students in meetings in regards to fellow students being addicted to drugs,”

This latest rollout will be in addition to 160 other school districts in Missouri.

The logistics for Belton County consist of 25 students in both middle and high schools that will be required to give a urine sample and be randomly tested each month.

If a student fails a test, they are immediately suspended from their activity, lose their parking pass and are offered counseling.  Also as a results of a failed test, the student will be automatically tested again the following month and if there are three positive drug tests, it would result in the student getting permanently suspended from the activity.


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here
 

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

Two synthetic drugs pose threat to public health. What are they?

Sep 19 2016

Two synthetic drugs pose threat to public health. What are they?

Cannabinoids and Cathinones are the latest synthetic drugs to bring on warnings issued by the Federal Government. 

Cannabinoids

Cannabinoids is often referred to as synthetic marijuana, K2 or Spice and can be found in legal retail outlets sold under “herbal incense” or “potpourri”.

  • Synthetic cannabinoids, contain approximately 120 known chemical variants with 50 or so of these chemical either regulated by U.S. law, or that are illegal in the United States.
  • China produces the bulk of synthetic marijuana where the “recipe” is altered to circumvent U.S. Law.
  • Cannabinoids are typically sold in packets which carry one of more than 500 brand names commonly referred to as Spice, Ace of Spades, Demon, King John Pot Pourri, Mojo and Mr. Bad Guy.
  • These products are labeled “not for human consumption” therefore, they are not regulated by the Food and Drug Administration. Cannabinoids and other synthetic drugs can also be purchased via internet
  • click here. To view a detailed list of over 500 Cannabinoids.

What are the risks of cannabinoids?

Some side effects of synthetic cannabinoids consist of severe agitation, anxiety, nausea, vomiting, heart palpitations, elevated blood pressure, tremors, seizures, hallucinations and dilated pupils. In some cases, suicidal and other harmful thoughts and/or actions have also been reported.

Cathinones

Cathinones, a naturally occurring stimulant found in the leaves of khat (the leaves of an Arabian shrub, which are chewed (or drunk as an infusion) as a stimulant. Khat is used in combination with other chemicals to make a drug similar to amphetamines.

  • Synthetic cathinone products often consist of methylenedioxypyrovalerone (MDPV), mephedrone, and methylone.
  • Similar to cannabinoids, most cathinones are produced in China. They are referred to as “bath salts,” and distributed under trade names such as ‘Ivory Wave’, ‘White Lightning’ and ‘Vanilla Sky.’ They are also labeled as “not for human consumption” to avoid penalty under the Analogue Enforcement Act.
  • Generally, Bath Salts are snorted, but some smoke it, inject it or ingest it as a pill.

What’s the risk of cathinones?

• The risk in the synthetic cathinones come from a complete lack of knowledge as to what and how much of any substance is in the drug.  It is very easy for someone to overdose on a cathinone.

Similar to the adverse effects of cocaine, LSD, and methamphetamine, synthetic cathinone use is most commonly associated with an increased heart rate, blood pressure, chest pain, extreme paranoia, hallucinations, delusions, and violent behavior.

What is the government doing?

The Synthetic Drug Abuse Prevention Act, which is part of the FDA Safety and Innovation Act of 2012, placed 26 types of synthetic cannabinoids and cathinones into Schedule I of the Controlled Substances Act (CSA)  – meaning they are illegal to possess or distribute. The problem with legislating against synthetic drugs is that they are altered so quickly.


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here
 

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

The CDC Provides Crucial New Guidance on Opioids and Pain

Sep. 12 2016

The CDC Provides Crucial New Guidance on Opioids and Pain

Millions of Americans suffer from opioid use disorders involving prescription pain medications, and each day approximately 40 people fatally overdose on them. Granted these medications may have a legitimate and important role in the treatment of severe acute pain and even some severe chronic pain conditions, it remains clear that they are being overprescribed or prescribed without suitable safeguards and monitoring.  This has significantly contributed to the shocking rise in opioid use disorders and to the related resurgence of heroin.

In April 2016, the Centers for Disease Control and Prevention (CDC) took a major step towards addressing this interconnected crisis by issuing new guidelines for prescribers.  These guidelines reference the use of opioids for treating patients who are diagnosed with chronic pain.  Recent studies indicate that approximately 70 percent of the opioids dispensed in the U.S. are used for that purpose. The CDC recommends that opioids should not be used as the first option or the only treatment for patients who suffer from chronic non-cancer pain.

The new guidelines recommend that non-opioid therapies, for example non-steroidal anti-inflammatory drugs (NSAIDS) like aspirin and ibuprofen, as well as non-drug treatments such as exercise and cognitive behavioral therapy, should be considered in the place of or in combination with opioid medications. When opioids are prescribed, physicians are encouraged to prescribe the lowest effective dose and closely monitor and follow-up with their patients.  Notably, the new guidelines do not apply to treatment of cancer pain or end-of-life care.

The published guidelines are the result of an extensive process in which all available scientific data were reviewed and the CDC also sought out input from experts and multiple stakeholders, including NIDA and other Federal agencies. The guidelines address one of the prongs of the HHS Secretary’s Opioid Initiative—to improve pain prescribing practices and physician education in pain treatment. Although these guidelines are not rules that legally bind doctors in their treatment of pain patients, they do provide guidelines that would serve as valuable advice that physicians, who currently receive little training in pain management, will welcome. This is a great first step for not only safer but also more effective pain management in our country.


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here

John Burgos, CPC
Business Development Manager
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

Marijuana-testing-workplace

Colorado Supreme Court: Employers can fire for off-duty pot use

Employers’ zero-tolerance drug policies trump Colorado’s medical marijuana laws, the Colorado Supreme Court ruled Monday.

In a 6-0 decision, the high court affirmed lower court rulings that businesses can fire employees for the use of medical marijuana — even if it’s off-duty.

With the ruling, which was a blow to some medical marijuana patients and a sigh of relief to employers, Colorado became the first state to provide guidance on a gray area of the law.

The decision came nine months after the state’s highest court heard oral arguments in Brandon Coats’ case against Dish Network. Coats became quadriplegic in a car accident and used marijuana to control leg spasms. He had a medical marijuana card and consumed pot off-duty. He was fired in 2010 after failing a random drug test.

Brandon Coats listens as his attorney talks Monday about his case. Coats said he is disappointed in the state Supreme Court ruling that businesses can fire
Brandon Coats listens as his attorney talks Monday about his case. Coats said he is disappointed in the state Supreme Court ruling that businesses can fire employees for the use of marijuana even if it’s for medical purposes and even if it’s done off-duty. (Kathryn Scott Osler, The Denver Post)
Coats, who was a customer service representative for Dish, challenged the Douglas County satellite TV company’s zero-tolerance drug policy, claiming that his use was legal under state law. His firing had been upheld in both trial court and the Colorado Court of Appeals.

DOCUMENT: Colorado Supreme Court affirms ruling

When the case went to the state Supreme Court, legal observers said the case could have significant implications for employers across Colorado. They noted that the ruling also could be precedent-setting as Colorado and other states wrangle with adapting laws to a nascent industry that is illegal under federal law.

At the crux of the issue was whether the use of medical marijuana — which is in compliance with Colorado’s Medical Marijuana Amendment — was “lawful” under the state’s Lawful Off-Duty Activities Statute.

THE CANNABIST
Colorado Marijuana News Site
More Denver Post marijuana coverage at The Cannabist
See a map of Colorado’s recreational marijuana shops
Recent Cannabist news
Study: Heavy pot use linked to short-term memory issues in middle age
‘Nuns’ on a mission from God to keep California’s medical pot plentiful
Cannabist Calendar: Bob Marley’s big day, romance & more in February 2016
That term, the justices said, refers to activities lawful under both state and federal law.

“Therefore, employees who engage in an activity, such as medical marijuana use, that is permitted by state law but unlawful under federal law are not protected by the statute,” Justice Allison H. Eid wrote in the opinion.

Current Colorado law allows employers to set their own policies on drug use.

Coats’ attorney Michael Evans, of Centennial-based The Evans Group, called the decision “devastating.”

He said he does not plan to take the case to the U.S. Supreme Court.

“You need the Colorado Supreme Court to stand up for its own laws,” he said. “The U.S. Supreme Court is not going to do that.”

Resolution at last

On Monday, Coats and his mother, Donna Scharfenberg, spent all morning refreshing the Colorado Supreme Court’s website. When they finally read the ruling, there was 10 minutes of silence.

“It was just kind of shocking,” Coats said. “There was a silent moment there for a long while.”

It was a disappointing resolution to what has been a five-year battle for Coats, who is unemployed.

“This is a controversial issue,” he said. “This is a hard case, and it was going to be a hard case to win. I was definitely hoping it would go the other way around.

“I was feeling like maybe, maybe, but it didn’t go that way.”

Officials with Douglas County-based Dish lauded the decision.

“We are pleased with the outcome of the court’s decision today,” the company said in a statement. “As a national employer, Dish remains committed to a drug-free workplace and compliance with federal law.”

Colorado Attorney General Cynthia H. Coffman said the decision gives companies the freedom to craft their own employment policies concerning marijuana.

“Not every business will opt for zero-tolerance, but it is important that the latitude now exists to craft a policy that fits the individual workplace,” she said.

A question for the legislature

When Colorado legalized recreational marijuana last year, employers across the state increased their drug testing, said Curtis Graves, an attorney for Mountain States Employers Council, referencing a workplace survey at the time. A year later, and with an unemployment rate below 5 percent, some employers have loosened the reins.
“We’ve seen a number of employers, particularly in hospitality … who are actually omitting THC from a pre-employment drug screen,” he said.

The market might dictate a further shift in the future.

Until then, people like Coats will have to consider other treatments or find a position that does not enforce a zero-tolerance drug policy, said Austin Smith, managing shareholder of employment law firm Ogletree Deakins’ Denver office.

“It puts employees in a tough spot,” said Smith, who watched the case closely but was not involved.

Sam Kamin, a University of Denver law professor, said the justices’ decision comes as no surprise.

“It’s easy to make too much of this decision,” he said. “It really comes down to interpreting this one word (‘lawful’) in this one statute.”

As a matter of statutory interpretation, the court got it right, he said.

But for Coats and medical marijuana advocates, this is a blow, Kamin said. He said he thinks the state legislature will take up the issue.

“I think (Coats’) case is very sympathetic, and I think his case would be quite compelling before the legislature,” Kamin said.

Six of the seven justices decided the case. Justice Monica Marquez recused herself because her father, retired Senior Judge Jose D.L. Marquez, was on the Court of Appeals panel that upheld Coats’ firing.

Alicia Wallace: 303-954-1939, awallace@denverpost.com or twitter.com/aliciawallace

Excerpts from the Colorado Supreme Court decision

• “Colorado’s ‘lawful activities statute,’ the term ‘lawful’ refers only to those activities that are lawful under both state and federal law.”

• “Nothing in the language of the statute limits the term ‘lawful’ to state law. Instead, the term is used in its general, unrestricted sense, indicating that a ‘lawful’ activity is that which complies with applicable ‘law,’ including state and federal law. We therefore decline Coats’s invitation to engraft a state law limitation onto the statutory language.”

• “Coats does not dispute that the federal Controlled Substances Act prohibits medical marijuana use. The CSA lists marijuana as a Schedule I substance, meaning federal law designates it as having no medical accepted use, a high risk of abuse, and a lack of accepted safety for use under medical supervision.”

• “Having decided this case on the basis of the prohibition under federal law, we decline to address the issue of whether Colorado’s Medical Marijuana Amendment deems medical marijuana use ‘lawful’ by conferring a right to such use.”

on

Brazil Olympic team’s number of drug-test samples questioned

Aug 10 2016

Olympic Drug Test Samples Questioned
(Photo by Cameron Spencer/Getty Images)

Brazil’s Olympic team gave about a third as many samples as normally expected in the crucial month before the games began, CNN can reveal — an “unacceptable practice” according to the world anti-doping watchdog.

The host nation has already been sanctioned by the World Anti-Doping Agency, or WADA, over concerns its testing of its own athletes ahead of the Games was delayed, and perhaps compromised. Yet CNN has learned there may not actually be enough samples to test to give the team — the second largest at the games — a clean record for July. This is because Brazilian athletes gave a significantly reduced number of samples in the first three weeks of July.
The World Anti-Doping Agency said the gap in samples collected by Brazil’s anti-doping agency was “unacceptable practice … particularly at such a crucial time before the Olympic Games.” It added: “These numbers are not in line with an effective program.” The spokesman said it may have left a “big gap.”
A spokesman for the Brazilian Ministry of Sport, Paulo Rossi, told CNN the Brazilian team of 477 athletes gave a total of 110 samples in the first 24 days of July. He described the average amount they would be expected to give in that period “as I think about 300,” or possibly less.
The reduced number of samples is a serious issue for Brazil, the host nation of an Olympic Games swamped in the geopolitical and moral impact of doping. The Russian Paralympic team has been banned. The Russian Olympic team has faced calls for a ban, and, while nearly all its track and field athletes have been banned, a lengthy International Olympic Committee mechanism to vet their remaining team members led to the vast majority of them being allowed to compete.
The Brazilian Ministry of Sport said the “allegation is absurd and makes no sense.” They added the Brazilian National Anti-Doping Organistaion, NADO, “under the Ministry of Sport, follows international codes to the letter and is committed to consolidating anti-doping policy in Brazil.”
Brazil’s problems began with the nearly monthlong suspension of the only laboratory in the country accredited by the World Anti-Doping Agency to carry out anti-doping tests, causing delays in the testing of samples the team did give. It was unclear why the laboratory was suspended. Yet the greatly reduced number of samples the team gave in July means there is now a hole in the samples that can be retrospectively tested for the month ahead of the Games, a period the doping watchdog deems “crucial.” The Brazilian laboratory has since had its accreditation by WADA restored and will process 6,000 samples from all countries competing during the Games.
A spokesman for WADA, Ben Nichols, told CNN in an email: “We wrote to the ministry pressing our concerns and demanding to know why testing had stopped. The response was not satisfactory, and the situation was unacceptable.” Nichols confirmed 110 samples had been collected for testing in the July 1-24 period.
However, Rossi said Brazil’s anti-doping agency was struggling to process samples because its laboratory had been suspended. He said WADA was aware of the issue, and blamed the problems on WADA suspending the laboratory. The Brazilian Ministry of Sport said in its statement that 2,227 tests had been done in Brazil between January 1 and June 22, when the laboratory was suspended.
WADA said the Brazilian anti-doping authority should have — as part of established practices in sport — sent all Brazil’s samples to another laboratory during the period in which the main laboratory in Brazil was suspended. The Brazilian Ministry of Sport said the partner laboratories their anti-doping agency could have used included one in Spain — which was also suspended by WADA — and laboratories in Portugal and Colombia, which Rossi said were unable to take on the task.
WADA spokesman Nichols said the agency had repeatedly told Brazilian officials the situation was unsatisfactory and notified Olympic officials in “the pre-Olympics task force with our concerns, and requested that there be increased testing on Brazilian athletes.”
The International Olympic Committee said, through spokeswoman Emmanuelle Moreau, that its task force was meant to assess which athletes might need extra scrutiny, but not carry out the tests itself, as that was the job of doping agencies. She did not comment on the reduced level of sampling.


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here

Brandon Rains
Director Of Online Marketing
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

Publix Donates $800,000 to Fight Medical Marijuana Legalization in Florida


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here
Brandon Rains
Director Of Online Marketing
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc

on

How Long Do Drugs Stay In Your System?

July 11 2016

How Long Do Drugs Stay In Your System?

 

Some open-minded, liberal experts would agree that drug use should not be a punishable offense, the fact is that if you happen to be an athlete, a DOT regulated employee, working for a company with a drug free workplace program or just the child of  concerned parents, you could be subjected to a drugs test. So How Long Do Drugs Stay In Your System?

Once drugs are absorbed into the bloodstream – which can occur via the lungs, the digestive tract, or even a syringe – the only way to get them out is by excretion. Depending on what you’ve taken, some may pass straight through you relatively quickly, coming out in your poop. Much of the rest will eventually be released in your urine and sweat. However, before this can happen, drugs have to be metabolized into water soluble molecules, or metabolites.

This process mostly occurs in the liver, which contains catalysts like cytochrome P450 enzymes that cause drugs to become oxidized. As a result, non-polar molecules – which have no overall charge and are therefore not soluble in water – become negative, much like a drug user on a comedown. Normally, these metabolites will then be ionized as well, ensuring that by the time the liver is through with them, they are well and truly ready to dissolve – just like the ego of someone on LSD.

By this stage, the acute effects of any drug will have worn off, and the soluble metabolites in a user’s system will dissolve into the water in their blood, before being filtered out by the kidneys and excreted as urine. This process can take a while, however, giving drug testers the chance to catch people with drug metabolites in their pee and blood.


For information regarding the effects of drug abuse – Click Here
For  information on a drug free work place – Click Here
For  information on substance abuse programs – Click Here
For information on DOT Drug / Alcohol Testing requirements – Click Here
Brandon Rains
Director Of Online Marketing
https://accrediteddrugtesting.net
(800) 221-4291
Accredited Drug Testing Inc
Health Screening USA Inc